The ongoing clinical trials of Brain-Computer Interfaces (BCIs) such as Neuralink’s “Telepathy” implant involve establishing communication links between...
Results from the phase2 trial support the view that subcutaneous administration of IFN- β for treatment of COVID-19 enhances speed of recovery and reduces mortality....
Scientists have designed a new chest-laminated, ultrathin, 100 percent stretchable cardiac sensing electronic device (e-tattoo) to monitor heart functions. The device can measure ECG,...
Scientific research has proven that dogs are compassionate beings who overcome obstacles to help their human owners.
Humans have domesticated dogs for thousands of years...
A combination of biological and computational approach to study protein-protein interactions (PPIs) between the viral and the host proteins in order to identify and...
Rezdiffra (resmetirom) has been approved by the FDA of the USA for the treatment of adults with noncirrhotic non-alcoholic steatohepatitis (NASH) with moderate to...
Concizumab (commercial name, Alhemo), a monoclonal antibody was approved by the FDA on 20 December 2024 for prevention of bleeding episodes in patients with...
A novel treatment which “prevents” oesophageal cancer in at-risk patients is reported in a large clinical trial.
Oesophageal cancer is the eight most common cancer...
LignoSat2, the first wooden artificial satellite developed by Kyoto University’s Space Wood Laboratory is scheduled to be jointly launched by JAXA and...
The APXC instrument aboard the lunar rover of ISRO’s Chandrayaan-3 moon mission conducted in-situ spectroscopic study to ascertain abundance of elements...